- NZ$18.28m
- NZ$49.21m
- NZ$25.81m
- 58
- 93
- 90
- 94
Annual income statement for Vital, fiscal year end - June 30th, NZD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | C2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 34.6 | 30.7 | 27.5 | 26.2 | 25.8 |
| Cost of Revenue | |||||
| Gross Profit | 13.7 | 11.1 | 12 | 12.2 | 11.9 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 31.6 | 48.4 | 24.8 | 23.2 | 27 |
| Operating Profit | 2.99 | -17.7 | 2.69 | 2.96 | -1.21 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 1.16 | -19.9 | -0.275 | -0.068 | -3.92 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 0.841 | -19.1 | -0.183 | 0.027 | -2.81 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 0.841 | -19.1 | -0.183 | 0.027 | -2.81 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 0.841 | -19.1 | -0.183 | 0.027 | -2.81 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.02 | -0.193 | -0.004 | 0.001 | -0.011 |
| Dividends per Share | |||||
| Special Dividends per Share |